H Cyte Inc's Cash & cash equivalent grew by % in the Q1 2023 sequentially, faster than Current Liabilities, this led to improvement in H Cyte Inc's Quick Ratio to 0.01, Quick Ratio remained below H cyte Inc average.

Within Medical Equipment & Supplies industry 254 other companies have achieved higher Quick Ratio than H Cyte Inc in first quarter 2023. While Quick Ratio total ranking in the first quarter 2023 has deteriorated compared to the prior quarter from 0 to 5970.

Explain Quick Ratio?
How much Cash & cash equivalents HCYT�s has?
What are HCYT�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

HCYT Quick Ratio	(Mar 31 2023) Q1	(Dec 31 2022) Q4	(Sep 30 2022) Q3	(Jun 30 2022) Q2	(Mar 31 2022) Q1
Y / Y Current Liabilities Change	101.4 %	51.94 %	41.52 %	-6.29 %	49.64 %
Y / Y Cash & cash equivalent Change	-66.01 %	-	-88.05 %	-96.97 %	2.7 %
Quick Ratio MRQ	0.01	-	0.01	0.01	0.07
HCYT's Total Ranking	# 5970	# 0	# 6110	# 4791	# 5371
Seq. Current Liabilities Change	29.2 %	11.71 %	29.32 %	7.91 %	-2.53 %
Seq. Cash & cash equivalent Change	-	-	-19.95 %	-86.56 %	258.6 %

Quick Ratio first quarter 2023 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 255
Healthcare Sector	# 1262
Overall Market	# 5970

Quick Ratio Statistics
High	Average	Low
6.85	1.2	0.01
(Jun 30 2015)		(Sep 30 2022)

Financial Statements
H Cyte Inc's Current Liabilities	$ 10 Millions	Visit HCYT's Balance sheet
H Cyte Inc's Cash & cash equivalent	$ 0 Millions	Visit HCYT's Balance sheet
Source of HCYT's Sales		Visit HCYT's Sales by Geography

Cumulative H Cyte Inc's Quick Ratio

HCYT's Quick Ratio for the trailling 12 Months

HCYT Quick Ratio	(Mar 31 2023) 12 Months	(Dec 31 2022) 12 Months	(Sep 30 2022) 12 Months	(Jun 30 2022) 12 Months	(Mar 31 2022) 12 Months
Y / Y Current Liabilities TTM Growth	45.25 %	31.36 %	32.02 %	33.97 %	49.58 %
Y / Y Cash & cash equivalent TTM Growth	-91.21 %	-81.17 %	-86.33 %	-88.6 %	-68.78 %
Quick Ratio TTM	0.01	0.02	0.02	0.04	0.11
Total Ranking TTM	# 5693	# 5689	# 3653	# 4624	# 4303
Seq. Current Liabilities TTM Growth	20.15 %	11.84 %	10.01 %	-1.74 %	8.66 %
Seq. Cash & cash equivalent TTM Growth	-53.14 %	-18.34 %	-34.26 %	-65.07 %	0.4 %

Quick ratio ranking by company, industry and sector >> Back to HCYT Financial Strength Comparisons >> Go to Compare HCYT Quick Ratio to its Competitors

On the trailing twelve months basis Due to unchanged in Current Liabilities in the Q1 2023 to $9.66 millions, cumulative Quick Ratio decreased to 0.01 below the H Cyte Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 251 other companies have achieved higher Quick Ratio than H Cyte Inc. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2022 from 5689 to 5693.

Explain Quick Ratio?
How much Cash & cash equivalents HCYT�s has?
What are HCYT�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 252
Healthcare Sector	# 1220
Within the Market	# 5693

trailing twelve months Quick Ratio Statistics
High	Average	Low
2.81	0.46	0.01
(Dec 31 2017)		(Mar 31 2023)

Companies with similar Quick Ratio in the quarter ending Mar 31 2023, within Medical Equipment & Supplies Industry	Quick Ratio	Mar 31 2023 MRQ Cash & cash equivalent	Mar 31 2023 MRQ Current Liabilities
Trisalus Life Sciences Inc	0.03	$ 0.137 Millions	$ 4.664 Millions
Non Invasive Monitoring Systems Inc	0.03	$ 0.018 Millions	$ 0.617 Millions
P3 Health Partners Inc	0.03	$ 7.183 Millions	$ 269.661 Millions
Northview Acquisition Corp	0.02	$ 0.056 Millions	$ 2.311 Millions
Fuse Medical Inc	0.02	$ 0.211 Millions	$ 11.287 Millions
Infusystem Holdings Inc	0.02	$ 0.256 Millions	$ 13.930 Millions
Holdco Nuvo Group D g Ltd	0.02	$ 0.553 Millions	$ 30.945 Millions
Stimcell Energetics Inc	0.02	$ 0.008 Millions	$ 0.430 Millions
Envoy Medical Inc	0.02	$ 0.104 Millions	$ 6.369 Millions
Altitude Acquisition Corp	0.02	$ 0.031 Millions	$ 2.026 Millions
Smith and Nephew Plc	0.01	$ 33.000 Millions	$ 2,271.000 Millions
Vycor Medical Inc	0.01	$ 0.054 Millions	$ 3.786 Millions
United Health Products Inc	0.01	$ 0.032 Millions	$ 2.280 Millions
Yunhong Green Cti Ltd	0.01	$ 0.130 Millions	$ 9.288 Millions
Wearable Health Solutions, Inc.	0.01	$ 0.016 Millions	$ 1.214 Millions
Global Innovative Platforms Inc.	0.01	$ 0.003 Millions	$ 0.242 Millions
H cyte Inc	0.01	$ 0.116 Millions	$ 9.660 Millions
Medicale Corp.	0.01	$ 0.000 Millions	$ 0.018 Millions
Therapeutic Solutions International Inc	0.01	$ 0.019 Millions	$ 2.255 Millions
Oceantech Acquisitions I Corp	0.01	$ 0.016 Millions	$ 3.065 Millions
Blueriver Acquisition Corp	0.01	$ 0.010 Millions	$ 1.838 Millions
Arch Therapeutics Inc	0.00	$ 0.029 Millions	$ 7.979 Millions
Vsee Health Inc	0.00	$ 0.016 Millions	$ 5.013 Millions
Vystar Corporation	0.00	$ 0.016 Millions	$ 6.066 Millions

Date modified: 2026-09-08T15:10:58+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.